Ron C.J. Schackmann

1.4k total citations
15 papers, 974 citations indexed

About

Ron C.J. Schackmann is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ron C.J. Schackmann has authored 15 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ron C.J. Schackmann's work include HER2/EGFR in Cancer Research (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cancer Cells and Metastasis (4 papers). Ron C.J. Schackmann is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cancer Cells and Metastasis (4 papers). Ron C.J. Schackmann collaborates with scholars based in United States, Netherlands and United Kingdom. Ron C.J. Schackmann's co-authors include Patrick W.B. Derksen, Joan S. Brugge, Milou Tenhagen, Laura M. Selfors, Robert A. H. van de Ven, Judy E. Garber, Jennifer M. Rosenbluth, G. Kenneth Gray, Carman Man-Chung Li and Hans Clevers and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Ron C.J. Schackmann

15 papers receiving 965 citations

Peers

Countries citing papers authored by Ron C.J. Schackmann

Since Specialization

Citations

This map shows the geographic impact of Ron C.J. Schackmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron C.J. Schackmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron C.J. Schackmann more than expected).

Fields of papers citing papers by Ron C.J. Schackmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron C.J. Schackmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron C.J. Schackmann. The network helps show where Ron C.J. Schackmann may publish in the future.

Co-authorship network of co-authors of Ron C.J. Schackmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ron C.J. Schackmann. A scholar is included among the top collaborators of Ron C.J. Schackmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron C.J. Schackmann. Ron C.J. Schackmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Abstract 1903: Zenocutuzumab, a HER2xHER3 bispecific antibody, is effective in cancer models with high NRG1 expression 2024 ·Cancer Research ·Marie O’Connor, Ron C.J. Schackmann, Igor Odintsov, Szabolcs Fátrai, Arie B. Brinkman, Sidney P. Walker, Jeroen J. Lammerts van Bueren, Cecile Geuijen	1
2	A human breast atlas integrating single-cell proteomics and transcriptomics 2022 ·Developmental Cell ·G. Kenneth Gray, Carman Man-Chung Li, Jennifer M. Rosenbluth, Laura M. Selfors, Nomeda Girnius, Jia‐Ren Lin, Ron C.J. Schackmann, Walter L. Goh, Kaitlin Moore, (unknown), Shaolin Mei, Kurt D’Andrea, Katherine L. Nathanson, Peter K. Sorger, Sandro Santagata, Aviv Regev, Judy E. Garber, Deborah Dillon, Joan S. Brugge	76
3	Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts 2021 ·Oncogene ·Hendrik J. Kuiken, Sabin Dhakal, Laura M. Selfors, (unknown), Tian Zhang, Maurizio Callari, Ron C.J. Schackmann, G. Kenneth Gray, Jett Crowdis, Hyo-Eun Carrie Bhang, Timour Baslan, Frank Stegmeier, Steven P. Gygi, Carlos Caldas, Joan S. Brugge	5
4	Abstract 956: The HER2×HER3 bi-specific antibody Zenocutuzumab is effective at blocking growth of tumors driven by NRG1 gene fusions 2021 ·Cancer Research ·Igor Odintsov, Inna Khodos, (unknown), (unknown), Marissa S. Mattar, Alison M. Schram, Ron C.J. Schackmann, Jeroen Lammerts van Bueren, Cecile Geuijen, Elisa de Stanchina, Marc Ladanyi, Romel Somwar	1
5	Abstract P201: Zenocutuzumab is an effective HER2/HER3 Biclonics® antibody in cancers with NRG1 fusions 2021 ·Molecular Cancer Therapeutics ·Jan P. Gerlach, Igor Odintsov, Ron C.J. Schackmann, Marc Ladanyi, Jeroen Lammerts van Bueren, Romel Somwar, Cecile Geuijen	3
6	A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma 2020 ·Nature Medicine ·Fathima Zumla Cader, Xihao Hu, Walter L. Goh, Kirsty Wienand, Jing Ouyang, Elisa Mandato, Robert Redd, Lee N. Lawton, Pei-Hsuan Chen, Jason L. Weirather, Ron C.J. Schackmann, Bo Li, Wenjiang Ma, Philippe Armand, Scott J. Rodig, Donna Neuberg, X. Shirley Liu, Margaret A. Shipp	88
7	Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages 2020 ·Nature Communications ·Jennifer M. Rosenbluth, Ron C.J. Schackmann, G. Kenneth Gray, Laura M. Selfors, Carman Man-Chung Li, (unknown), Hendrik J. Kuiken, Andrea L. Richardson, Jane Brock, Judy E. Garber, Deborah Dillon, Norman Sachs, Hans Clevers, Joan S. Brugge	165
8	Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment 2018 ·Blood ·Fathima Zumla Cader, Ron C.J. Schackmann, Xihao Hu, Kirsty Wienand, Robert Redd, Bjoern Chapuy, Jing Ouyang, Nicole Paul, Evisa Gjini, Mikel Lipschitz, Philippe Armand, David Wu, Jonathan R. Fromm, Donna Neuberg, X. Shirley Liu, Scott J. Rodig, Margaret A. Shipp	111
9	Rapid Sequential in Situ Multiplexing with DNA Exchange Imaging in Neuronal Cells and Tissues 2017 ·Nano Letters ·Yu Wang, Johannes B. Woehrstein, (unknown), Mingjie Dai, Mauricio Avendaño, Ron C.J. Schackmann, Jason J. Zoeller, Shan Shan H. Wang, Paul W. Tillberg, Demian Park, Sylvain W. Lapan, Edward S. Boyden, Joan S. Brugge, Pascal S. Kaeser, George M. Church, Sarit S. Agasti, Ralf Jungmann, Peng Yin	110
10	Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP 2016 ·Science Signaling ·(unknown), Wendy Lee, Anne White, J. Wade Harper, Ron C.J. Schackmann, Michael Overholtzer, Laura M. Selfors, Joan S. Brugge	46
11	Nuclear p120-catenin contributes to anoikis resistance of Lobular Breast Cancer through Kaiso-dependent Wnt11 expression 2015 ·Disease Models & Mechanisms ·Robert A. H. van de Ven, Milou Tenhagen, Wouter Meuleman, (unknown), Ron C.J. Schackmann, Patrick W.B. Derksen	25
12	Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling 2013 ·Cancer Research ·Ron C.J. Schackmann, Sjoerd Klarenbeek, Eva J. Vlug, Suzan Stelloo, Miranda van Amersfoort, Milou Tenhagen, Tanya M. Braumuller, Jeroen F. Vermeulen, Petra van der Groep, Ton Peeters, Elsken van der Wall, P. J. van Diest, Jos Jonkers, Patrick W.B. Derksen	48
13	p120-catenin in cancer – mechanisms, models and opportunities for intervention 2013 ·Journal of Cell Science ·Ron C.J. Schackmann, Milou Tenhagen, Robert A. H. van de Ven, Patrick W.B. Derksen	72
14	Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance 2011 ·Journal of Clinical Investigation ·Ron C.J. Schackmann, Miranda van Amersfoort, Judith H.I. Haarhuis, Eva J. Vlug, Vincentius A. Halim, Jeanine M.L. Roodhart, Joost S.P. Vermaat, Emile E. Voest, Petra van der Groep, P. J. van Diest, Jos Jonkers, Patrick W.B. Derksen	107
15	Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells 2010 ·Gastroenterology ·Frederik J.H. Hoogwater, Maarten W. Nijkamp, Niels Smakman, Ernst J.A. Steller, Benjamin L. Emmink, B. Florien Westendorp, Daniëlle Raats, Martin R. Sprick, Uta Schaefer, Winan J. van Houdt, Menno T. de Bruijn, Ron C.J. Schackmann, Patrick W.B. Derksen, Jan Paul Medema, Henning Walczak, Inne H.M. Borel Rinkes, Onno Kranenburg	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact